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A series of N-alkylated analogues of 1-deoxynojirimycin containing a ﬂuorescent 10-chloro-9-anthracene
group in the N-alkyl substituent were prepared. The anthracene group acted as a reporting group for
protonation at the nitrogen in the iminosugar because an unprotonated amine was found to quench
ﬂuorescence by photoinduced electron transfer. The new compounds were found to inhibit b-
glucosidase from Phanerochaete chrysosporium and a-glucosidase from Aspergillus niger, with Ki values
in the low micro- to nanomolar range. Fluorescence and inhibition versus pH studies of the b-
glucosidase–iminosugar complexes revealed that the amino group in the inhibitor is unprotonated when
bound, while one of the active site carboxylates is protonated.Introduction
Iminosugars, or monosaccharide analogues with a nitrogen
atom in place of the oxygen atom in the ring,1 are natural
products found in some plants and microorganisms.2 Many
iminosugars are potent inhibitors of glycosidases, and the
iminosugar structure has been used as a pharmacophore in
drugs and drug candidates.3 Examples of such molecules are 1-
deoxynojirimycin (1), which is present in mulberries and clearly
mimics D-glucose in the pyranose form, and its derivatives
miglitol (2) and miglustat (3), which are drugs that have been
approved for the treatment of diabetes and Niemann–Pick
disease, respectively (Fig. 1).4
In these compounds the nitrogen atom is typically consid-
ered to be crucial for inhibitory activity, as the corresponding
oxygen,5 sulfur and carbon analogues are normally much
weaker inhibitors.6 Wong and collaborators concluded from
a QSAR-type analysis of iminosugars and other inhibitors of
almond b-glucosidase and yeast a-glucosidase that a positive
charge on the inhibitor was important for binding.6 Legler
similarly concluded that basic sugar analogues were most likely
protonated at the glycosidase active site, and he divided glyco-
sidases into two classes based on their mechanism of binding
basic inhibitors.7 The rst class, which contains the family 1
enzyme almond b-glucosidase, binds the inhibitor in the
neutral form and then uses an active site carboxylate toenhagen, Universitetsparken 5, DK-2100
m.ku.dk; Tel: +45 35320160
(ESI) available: NMR spectra of new
Fig. S1–S5 (19 pages). See DOI:
hemistry 2017protonate it. The second group, which contains the GH3 family
enzyme Aspergillus wentii b-glucosidase as an example, binds
the ammonium form of the inhibitor directly.8 One way of dis-
tinguishing between these two modes of inhibitor binding is
that only the second class bind inhibitors with a permanent
positive charge, such as glycosyl pyridinium ions or quaternary
ammonium compounds such as the dimethylated analogue of
1-deoxynojirimycin.9Nojirimycins could be reasonably expected
to be transition state (TS) analogue inhibitors, as 1, when
protonated, clearly resembles the glucosylium ion 4 (Fig. 1),
which is quite similar to the TS of acidic or spontaneous
glycoside hydrolysis.10 The Withers group addressed theFig. 1 Iminosugars and oxocarbenium ion 4.
Chem. Sci., 2017, 8, 7383–7393 | 7383
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View Article Onlinemimicry of iminosugar 1 and castanospermine to the TS of
Agrobacterium b-glucosidase (GH1 family).11 Poor correlations in
the double logarithmic plots of kcat/Km versus the Ki values of
similarly modied inhibitor and substrate analogues (free
energy relationship plots) led to the conclusion that iminosu-
gars are not transition state analogues, but rather charged
compounds that just happen to bind tightly.12 Gloster and
Davies also discussed the imperfections in the transition state
mimicry of iminosugars when they were analysed with rigorous
methods, such as free energy relationship plots or comparisons
of the enzyme and inhibitor pH proles.13 They suggested that
these striking observations might be related to the cationic
nature of iminosugars, which are frequently found to be very
potent inhibitors.14
Whether iminosugars are TS mimics or not, it is apparent
that it is the norm to assume that iminosugars are, or become,
protonated at the nitrogen atom when they bind to an enzyme.
However, because protonation within the active site is diﬃcult
to observe by X-ray or NMR,15 there is to our knowledge only one
example in the literature where the protonation state of an
iminosugar was denitively established.16 Davies and collabo-
rators used synchrotron radiation to obtain a high resolution
structure of an isofagomine derivative bound to a cellulase and
found the iminosugar in the ammonium form.16 Since the pKa
of isofagomine is very high (pKa 8.4), protonation is compara-
tively more likely in this case, and it is therefore far from certain
whether protonation occurs with the many less basic iminosu-
gars, such as 1, that have pKa values in the range of 3–7. We
therefore speculated whether the principle behind de Silva’s
uorescent pH indicators17a could be used for a more general
method to determine the protonation state of inhibitors in the
glycosidase active site (Fig. 2). In these indicators, the emission
from the uorescent chloroanthracene group is quenched by
photoinduced electron transfer (PET) from the lone pair of
a covalently attached amino group.17 When the amino group is
protonated, and the lone pair is involved in bonding, the PETFig. 2 Iminosugar–enzyme complex formation with the inhibitor as
a ﬂuorescent indicator. The protonated inhibitors are ﬂuorescent and
readily detected. The protonation behaviour of the enzyme can be
seen from the degree to which it changes the ratio between the
ﬂuorescent and non-ﬂuorescent inhibitor.
7384 | Chem. Sci., 2017, 8, 7383–7393process becomes unfavourable and uorescence returns. So an
iminosugar with a suitably attached chloroanthracene should
work as a uorescent indicator for the pH at the active site. In
order to obtain a full inventory of the protons in the active site,
it is necessary to combine these results with inhibition pH
dependency studies. Using our recent method, one can deter-
mine whether the inhibitor binds to the glycosidase with 0, 1, 2
or 3 protons in the complex (EI, EHI, EH2I or EH3I).18 Recently,
we tested the methodology with almond b-glucosidase and the
isofagomine derivative 5 (Fig. 1).19 It was found that 5 was
a good inhibitor and, surprisingly, bound to the enzyme as the
EI complex, which was conrmed by both uorescence and the
pH dependence of inhibition. In this work we have studied 1-
deoxynojirimycin derivatives such as 6 and their inhibition of
glycosidases, and have elucidated the protonation behaviour
during inhibition.Results
Synthesis
A series of 10-chloroanthracenyl derivatives of 1-deoxynojir-
imycin with diﬀerent chain lengths were prepared (6, 12 and 15)
in order to maximise the chance of enzyme inhibition and to
investigate the eﬀective distance of PET in this system. We also
needed a uorescence inhibitor where PET quenching could
not occur in order to check if the enzyme itself quenches uo-
rescence. For this we decided to make a 10-chloroanthracenyl
derivative of D-glucono-1,5-lactam (19), as D-glucono-1,5-lactam
is oen a good glucosidase inhibitor1b,5 and the amide is too
weak an electron donor to participate in PET.
The compound with the shortest tether (6) was prepared by
a diﬀerent method than the reductive amination we had
previously used,19 as that methodology appeared low yielding
and diﬃcult to reproduce. It was therefore made by alkylation
(Scheme 1). Commercially available aldehyde 7 was reduced
with NaBH4 in methanol to the alcohol 8 in a yield of 87%.
This compound was then converted with thionyl chloride
and pyridine to chloride 9 in 88% yield. The reaction of 1-
deoxynojirimycin with 9 and anhydrous K2CO3 in DMF at 80 CScheme 1 Synthesis of 6.
This journal is © The Royal Society of Chemistry 2017
Scheme 3 Synthesis of 15.
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View Article Onlinefor 4 h gave the pure alkylation product 6 in 48% yield. The
crude yield was higher and it is possible that some by-products
were formed, though these were not identied. The homo-
analogues of 6, however, were made by reductive amination.
Thus aldehyde 7 was reacted with a Wittig ylide made from
methoxymethyltriphenylphosphonium chloride and butyl
lithium to aﬀord the vinyl ether 10 in 60% yield (Scheme 2). The
vinyl ether was converted to the aldehyde by hydrolysis with
perchloric acid in reuxing aqueous ether, giving 11 in 89%
yield. Finally, reductive amination of 1-deoxynojirimycin (1)
with one equivalent of 11 and NaCNBH3 and acetic acid aﬀor-
ded the target conjugate 12 in 55% yield.
Further chain elongation with another methylene group was
performed by another round of Wittig homologation (Scheme 3).
The homoaldehyde 11 was reacted with methoxymethyl-
triphenylphosphonium ylide and gave the vinyl ether 13 in 53%
yield. Perchloric acid hydrolysis in reuxing aqueous ether gave
the aldehyde 14 in 78% yield, which was then coupled with 1-
deoxynojirimycin (1) by 1 : 1 reductive amination with NaCNBH3
and acetic acid. This gave the conjugate 15 in 82% yield. The
reason why the reductive amination of 1 is more successful with
aldehydes 11 and 14 is probably because they are aliphatic and
more readily form imines or even enamines.
The 10-chloroanthracenyl derivative of D-glucono-1,5-lactam
(19) was more diﬃcult to prepare, as reductive amination is not
possible and alkylation of the amide requires a strong base and
may not be selective for nitrogen. Also, the 10-chloroanthracene
is sensitive to reduction, which precludes the use of benzyl
groups and can make it complicated to introduce earlier in the
synthesis. However, eventually the relatively straightforward
procedure shown in Scheme 4 led to the compound: D-glucono-
1,5-lactam 16 (ref. 20) was persilylated with excess tert-butyldi-
methylsilyl triate in pyridine/DMAP at 60 C for 18 h. This gave
the product 17 in 60% yield in the familiar all-axial conformationScheme 2 Synthesis of 12.
Scheme 4 Synthesis of lactam 19.
This journal is © The Royal Society of Chemistry 2017caused by the bulky silyl groups. This can clearly be seen from the
change of the 2,3 proton coupling constant from 8.5 Hz in 16 to
3.5 Hz in 17 (Scheme 4). N-Alkylation of 17 with the chloromethyl
derivative 9 and sodium hydride in THF and tetrabutylammo-
nium iodide as a nucleophilic catalyst gave product 18 in 49%
yield. Finally, deprotection of 18 using tetrabutylammonium
uoride in THF gave 19 in 14% yield. The reason for the low yield
in this reaction is not clear.Acidity constants
The acidity constants of the 1-deoxy-nojirimycin derivatives
were determined by measuring the relative uorescenceChem. Sci., 2017, 8, 7383–7393 | 7385
Fig. 3 Fluorescence titration of 6 (black), 12 (red) and 15 (blue). Shown
is the ﬂuorescence intensity as a function of pH, normalized relative to
pH ¼ 2.
Table 1 pKa values of inhibitors 6, 12 and 15, and the literature pKa
value of inhibitor 1
Compound 6 12 15 1
pKa 5.15 5.24 5.92 6.7
Table 3 Acidity constants (pKa) of active site residues of b- and a-
glucosidase determined from the pH dependence of enzyme activity
Enzyme Source pKa(1) pKa(2)
b-Glucosidase Phanerochaete chrysosp. 4.0 5.9
a-Glucosidase Aspergillus niger 3.2 6.4
Fig. 4 1/Ki versus pH for the inhibition of b-glucosidase from Pha-
nerochaete chrysosporium by 12 (red, nM1) and 15 (blue, multiplied
by 2.5, nM1), both in phosphate buﬀer containing 10% DMSO. The
data is compared with the calculated curves for EHI binding (solid) and
EH2I binding (dashed).
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View Article Onlineintensity as function of pH (Fig. 3). Fitting titration curves to the
data gave the pKa values shown in Table 1.Fig. 5 1/Ki versus pH for the inhibition of a-glucosidase from Asper-
gillus niger by 6 (red, mM1) in phosphate buﬀer containing 10% DMSO.
The data is compared with the calculated curves for EHI binding (solid)
and EH2I binding (dashed).Enzyme inhibition
Compounds 6, 12, 15 and 19 were tested for inhibition of the
selected glycosidases. The enzyme substrates in these experi-
ments were 4-nitrophenyl a-D-glucopyranoside for the a-gluco-
sidases and 4-nitrophenyl b-D-glucopyranoside for the
b-glucosidases, the solvent was 50 mM phosphate buﬀer con-
taining 10% DMSO, and the reactions were monitored by
measuring the absorption at 400 nm. 6 was a competitive
inhibitor of one b-glucosidase and two a-glucosidases (Table 2),
while 12 and 15 only inhibited the b-glucosidase from Phaner-
ochaete chrysosporium. However, they were 300–500 times more
potent than 6, and 12 was the strongest inhibitor.Table 2 Inhibition constants (Ki) at pH 6.0 for the inhibition of b- and
a-glucosidases by 6, 12, 15 and 19. The Ki values were measured in
phosphate buﬀer containing 10% DMSO to ensure complete solubility.
NI means that no inhibition was observed.—means that the inhibition
was not investigated
Enzyme/Ki (mM) 6 12 15 19
b-Glucosidase (T. maritima) NI NI NI —
b-Glucosidase (P. chrysosp.) 2.7 0.0062 0.0103 24.3
b-Glucosidase (A. oryzae) NI NI NI 169
a-Glucosidase (A. niger) 1.04 NI NI 14.4
a-Glucosidase (S. cerevisiae) NI NI NI —
a-Glucosidase (T. maritima) NI NI NI —
a-Glucosidase (Bacillus sp.) NI NI NI —
a-Glucosidase (B. stearoth.) 93 NI NI —
7386 | Chem. Sci., 2017, 8, 7383–7393pH dependence of enzyme activity and inhibition
The pKa values of the enzyme active site residues were deter-
mined from plots of the enzyme activity at diﬀerent pH values.
Fitting the theoretical function for the divalent acid that is
catalytic in the monoprotonated form gave the pKa values
shown in Table 3.
The pH dependence of inhibition was examined for 12 and
15 against b-glucosidase from Phanerochaete chrysosporium, and
for 6 against a-glucosidase from Aspergillus niger. These data are
plotted as 1/Ki versus pH in Fig. 4 and 5.
Fluorescence measurements
The compounds (6, 12, 15 and 19) all gave the characteristic
uorescence spectra of the 10-chloroanthracenes when excited
at 358 nm. As anticipated, lactam 19 displayed an unchangedThis journal is © The Royal Society of Chemistry 2017
Fig. 6 Fluorescence spectra of 19 (0.8 mM, black), in the presence of
b-glucosidase from P. chrysosporium (63 mM, blue) and in the pres-
ence of a-glucosidase from A. niger (54 mM, red). All solutions were at
pH 5.86 in 90% phosphate buﬀer and 10% DMSO.
Fig. 8 Fluorescence spectra of 6 (0.8 mM) at 3 diﬀerent pH values in
the presence and absence of a-glucosidase from A. niger (54 mM). All
the solutions were in 90% phosphate buﬀer and 10% DMSO.
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View Article Onlinespectrum at the full range of pH values, while the basic inhib-
itors 6, 12 and 15 displayed pH dependent uorescence as
anticipated (Fig. 3, ESI S1 & S3A†).
To check if the enzymes had a uorescence quenching eﬀect,
b-glucosidase from Phanerochaete chrysosporium and a-glucosi-
dase from Aspergillus niger were mixed with 19 at enzyme
concentrations above Ki (Fig. 6). The uorescence intensity from
19 showed minor decreases (10–20%) with both enzymes, but
conrmed that no signicant uorescence quenching from the
enzymes took place.
Mixing the strong binding deoxynojirimycin analogues 12
and 15 with b-glucosidase from Phanerochaete chrysosporium led
to a large decrease in uorescence for both inhibitors (Fig. 7 and
S4C–F†), independent of pH. Inhibitor 6 was only measured at
pH 6.0, where the uorescence intensity was nearly fully
quenched (Fig. S4A and B†).
Using 12 as the titrant, a uorescence titration of b-glucosi-
dase was conducted (Fig. S5†). This showed that the loss ofFig. 7 Fluorescence spectra of 12 (0.8 mM), in the presence of b-
glucosidase from P. chrysosporium (5.8 mM, blue) at 5 diﬀerent pH
values, and without the enzyme at two pH values. All the solutions
were in 90% phosphate buﬀer and 10% DMSO.
This journal is © The Royal Society of Chemistry 2017uorescence is associated with specic binding to the binding
site. When the binding site is full, no further loss of uores-
cence takes place.
Mixing 6 with a-glucosidase from Aspergillus niger had no
inuence on the uorescence from the inhibitor. Fluorescence
in the presence of this enzyme varied with pH in the same
manner as it did without (Fig. 8).Discussion
Photoinduced electron transfer has been reported to occur up to
10 A˚ (ref. 17), and in accordance with this we see eﬀective
uorescence quenching at basic pH for all the 1-deoxynojir-
imycin analogues (Fig. 3). However, the rate of the PET process
is also strongly distance dependent and for 15 the non-
protonated inhibitor displays approximately 10% residual
uorescence. Time-resolved uorescence measurements
conrm that this residual uorescence at high pH originates
from the deprotonated inhibitor (Fig. S2†). On the other hand,
no uorescence quenching was observed for lactam 19 and, as
anticipated, it displayed full uorescence over the entire pH
range (not shown).
The pKa values of 6, 12 and 15 of 5.15, 5.24 and 5.92 are
rather low compared to 1 (pKa 6.7). This is caused by steric
hindrance versus protonation in the tertiary amine, and the
inductive eﬀect from the aromatic system (the electron with-
drawing inuence of a benzyl group is 1.3 pH units21), which is
obviously larger when the chloroanthracene is closer to the
amine.
N-Alkylated iminosugar analogues are sometimes more
potent glycosidase inhibitors than their parent structures,1 but
this depends very much on the enzyme.9,22 In line with this, we
see that 6, 12, 15 and 19 only eﬀectively inhibit the b-glucosi-
dase from Phanerochaete chrysosporium and a-glucosidase from
Aspergillus niger (Table 2). Inhibition of the other enzymes is
non-existent or too weak to be practically useful in uorescence
measurements. The b-glucosidase from Phanerochaete chrys-
osporium (white rot fungus) is an extracellular enzyme whichChem. Sci., 2017, 8, 7383–7393 | 7387
Scheme 5 pH dependent inhibition of a divalent glycosidase by
a monobasic inhibitor. Legler’s two binding mechanisms are shown:
either binding of the unprotonated inhibitor (type 1) or binding of the
protonated inhibitor (type 2).
Table 4 pH values of optimum inhibition for compounds 6–19
Enzyme 6 12 15 19
b-Glucosidase (P. chrysosporium) 5.55 5.60 5.93 4.95
a-Glucosidase (A. niger) 5.78 — — 4.8
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View Article Onlineparticipates in the degradation of cellulose.23 It has been clas-
sied as a GH3 family enzyme.23 Inhibitors of this specic
enzyme have not been reported, but iminosugars such as 1 are
known to inhibit other GH3 b-glucosidases, such as the b-
glucosidase from Aspergillus wentii.1b,9a The a-glucosidase from
Aspergillus niger is an enzyme with high transglucosidase
activity.24 It is classied as a GH31 family enzyme. The chain-
extended analogues 12 and 15 are evidently particularly useful
for studying the inhibition of Phanerochaete chrysosporium b-
glucosidase as they are 3–500 times more potent than 6. On the
other hand, they display a complete loss of inhibition of
Aspergillus niger a-glucosidase.
In competitive inhibition, the pH dependence of inhibition
means that the inhibitor prefers to bind to the active site with
a specic number of protons. For a normal glycosidase with two
active site carboxylates and a monobasic iminosugar, four
complexes are possible (i.e. EI, EHI, EH2I or EH3I) and a general
binding scheme as outlined in Scheme 5 is expected. While
some of the pathways may be kinetically impossible for certain
enzymes, as Legler suggested, virtual equilibria will still exist
between the diﬀerent species due to the possibility of inter-
change by a diﬀerent pathway. The mutual interdependence of
the various equilibria means that it is not necessary to know theFig. 9 Curves for the pH dependence of the selective binding of
a monobasic inhibitor to a diacidic enzyme with 0, 1, 2 or 3 protons
when the pKa values of the enzyme (Bacteroides thetaiotaomicron a-
fucosidase) are 6.7 and 8.1 and the inhibitor pKa is 8.4 (FNJ). The actual
binding data for FNJ (black dots3c) show binding with the inhibitor and
enzyme fully protonated.
7388 | Chem. Sci., 2017, 8, 7383–7393pKa values of the various complexes. When the enzyme and
inhibitor pKa values are known, the pH-stability curves (Ki
1 vs.
pH) can easily be calculated using a spreadsheet (Fig. 9).18 In the
present cases, the data clearly t EHI binding for 6, 12 and 15
inhibiting b-glucosidase (Fig. 4) and for 6 inhibiting a-glucosi-
dase (Fig. 5). This means that one proton is bound either to the
amino group or to one of the carboxylate groups. Each of the
inhibitors has an optimum pH, as shown in Table 4. This
binding mode is the most common for iminosugar glycosidase
inhibitors in the literature,13,18 but there are exceptions andFig. 10 Protonation states of iminosugar–enzyme complexes. (A) EI
complex of isofagomine derivative 5 and almond b-glucosidase. (B)
EHI complex of 4-O-b-D-glucosyl isofagomine and cellulase from
Bacillus agaradhaerens, showing protonation on N. (C) EHI complex of
12 and b-glucosidase from P. chrysosporium, showing unprotonated
N. (D) EH3I complex of L-fuco-1-deoxynojirimycin with a-fucosidase
from Bacteroides thetaiotaomicron. (E) EHI complex of 6 and a-gluco-
sidase from A. Niger showing the amino-group exposed to the solvent.
This journal is © The Royal Society of Chemistry 2017
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View Article Onlinemore may emerge as only a fraction of inhibitors have been
analysed this way. The isofagomine derivative 5 binds to
almond b-glucosidase as the EI complex,19 and L-fuco-1-
deoxynojirimycin (FNJ, the L-fucose analogue of 1) appears to
bind to Bacteroides thetaiotaomicron a-fucosidase as the EH3I
complex, according the published binding data (Fig. 9).3c In
those two cases the existence of nitrogen protonation is evident,
as 5 must be unprotonated and FNJ must be protonated. This
can, to some extent, be explained by the pKa values of the
inhibitors. L-Fuco-1-deoxynojirimycin is very basic (pKa 8.4) and
is thus readily protonated, while 5 has a surprisingly low pKa
(5.1) and is thus more diﬃcult to protonate.
The disappearance of uorescence when 6, 12 and 15 bind to
P. chrysosporium b-glucosidase at pH 5 can only be interpreted
as the inhibitors being bound in the amine form. The proton
that we know is present must be bound to one of the carboxy-
lates, presumably the more basic residue (Fig. 10C). The
possibility that the observed uorescence quenching is caused
by an amino group in the protein (lysine or tryptophan) is
eliminated by the fact that only a small decrease in uorescence
is observed when lactam 19 is bound to the enzyme. For the
strong inhibitors 12 and 15, where essentially all the inhibitor
becomes bound, we see a residual uorescence of 10–15% from
the bound inhibitor. This could be consistent with a small
degree of protonation or could be due to incomplete PET
quenching in the specic geometry of the EI complexes, similar
to what is observed for inhibitor 15 in solution. It is noteworthy
here that the uorescence from the bound inhibitor is totally
independent of the solution pH and also of the pKa of the
inhibitor.
The nding that iminosugars bind to a GH3 b-glucosidase in
the amine form appears to contrast with Legler’s ndings that
a GH3 a-glucosidase binds the dimethylammonium analogue
of 1, which suggests that this family of enzymes likes to bind
cations.9 However, it could be that Legler’s a-glucosidase binds
1 as the amine, even though it binds the quaternary amine as
a cation, as this would also be fully consistent with the data.
The uorescence behaviour of 6 bound to a-glucosidase
from A. niger is surprisingly simple but is more enigmatic to
interpret. The uorescence of enzyme-bound 6, and thereby its
degree of protonation, follows the pH of the solution whether it
is bound to the enzyme or not. The simplest interpretation of
this is that the amino group is somehow exposed to the aqueous
medium (Fig. 10E), but since the inhibition pH dependence
shows a clear preference for EHI binding, the bound inhibitor
must be protonated at the same time as the mean deprotona-
tion of the enzyme.
There are now 5 cases where we know the degree of
protonation in iminosugar–glycosidase binding, and they are
remarkably diﬀerent (Fig. 10). In addition to the cellobioisofa-
gomine–cellulase complex, where the iminosugar is protonated
in an EHI complex (Fig. 10B),16 we also now know that FNJ must
be protonated in the a-fucosidase binding site since it binds as
the EH3I complex (Fig. 10D). At the other end of the spectrum, 5,
6, 12 and 15 do not bind to b-glucosidase as ammonium
compounds. Isofagomine 5 binds to almond b-glucosidase as
the EI complex (Fig. 10A),19 while 12 binds to P. chrysosporiumThis journal is © The Royal Society of Chemistry 2017b-glucosidase as the EHI complex, but as the amine (as do 6 and
15) (Fig. 10D). So why these diﬀerences? One signicant
diﬀerence between the protonated cases (Fig. 10B and D) and
the non-protonated cases (Fig. 10A and C) is that the inhibitors
are much more basic in the former (pKa 8.4) than in the latter
(pKa 5.1 and 5.25). More basic inhibitors are obviously more
likely to be protonated, as this will be energetically more
favourable. When the inhibitor is a weak base, it appears that
hydrogen bonding with the comparatively weak acid in the
enzyme active site is more favourable.
Finally, we have special case of 6 binding to a-glucosidase,
where the amine protonation is not xed but follows the pH
(Fig. 10E). The obvious explanation for this behaviour is that the
amino group of the inhibitor is exposed to the solvent. The
enzyme is known to be a trans-glucosidase, which could be an
indication of an open or spatially active site since the enzyme
has to accommodate large nucleophiles.
In any case, the ndings in this paper show that the
protonation of iminosugar inhibitors in glycosidase active sites
can by no means be anticipated.25 We observe nanomolar
inhibition of the iminosugars 12 and 15, where the amino group
stays unprotonated but presumably participates in hydrogen
bonding. The inhibitor is not transition state-like in terms of
charge, and any potential hydrogen bond between the amino
group and the enzyme does not resemble the hydrogen bonding
involved in substrate conversion. With the many iminosugar
inhibitors that are comparatively weak bases, it is likely that the
behaviour we see here is widespread.Conclusions
Glycosidases are sophisticated acid catalysts of glycoside
hydrolysis. It would therefore seem likely that basic inhibitors
that resemble the substrate would become protonated when
bound to the active site of the highly eﬃcient acid catalyst.
However, considering the results in this paper it is evident that
this is not always the case. In a number of cases the inhibitor
binds in the neutral form. This dispels the view of the interac-
tion of iminosugars with glycosidases as a base–acid interaction
in the traditional sense.Experimental
General information
Dry solvents were trapped from a solvent purication system.
Reactants were purchased from commercial sources and used
without further purication. HRMS were recorded on a Bruker
Solarix XR mass spectrometer analyzing TOF. Optical rotations
were measured on a Perkin-Elmer 341 digital polarimeter or
a Jasco P-2000 polarimeter with a path length of 1 dm. NMR
spectra were recorded on a Bruker 500 MHz spectrometer.
Chemical shis (d) are reported in ppm relative to the residual
solvent signals (CDCl3: d ¼ 7.26 for 1H-NMR and 77.16 ppm for
13C-NMR. DMSO-d6: d ¼ 2.50 for 1H-NMR and 39.52 ppm for
13C-NMR). Assignments were aided by COSY and HSQC
experiments.Chem. Sci., 2017, 8, 7383–7393 | 7389
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View Article OnlineThe enzymes were obtained from Megazyme. For the kinetic
studies the enzymes were simply diluted and used directly. For
uorescence studies the enzyme preparations from Megazyme
were added to 10 mM Na-phosphate buﬀer at pH 6.0 to solu-
bilize the crystals, then further dialyzed three times against 0.5
liters of 10 mM Na-phosphate buﬀer at pH 6.0, one time over-
night using a slide-a-lyzer (MWCO 10 kDa, 5–15 mL). Aer
harvesting the dialyzed protein sample, the protein concentra-
tion was determined by measuring the absorbance at 280 nm
with a Nanodrop ND-1000. Concentrations were calculated
using Mw 84 500 for b-glucosidase from P. chrysosporium23 and
116 000 for a-glucosidase from A. niger.24
10-Chloro-9-anthracenemethanol (8). 10-Chloro-9-anthra-
cenecarboxaldehyde (7, 125 mg, 0.512 mmol, 1 equiv.) was
suspended in methanol (10 mL) and cooled to 0 C. Sodium
borohydride (22 mg, 0.578 mmol, 1.1 equiv.) was added and the
mixture was stirred for 90 minutes, when TLC showed
a complete reaction. Water was added and the mixture was
extracted with diethyl ether. The collected ether phases were
dried with MgSO4 and concentrated. Aer subjection to
gradient column chromatography on silica gel with ethyl
acetate–heptane 1 : 4, then 1 : 3 and nally 9 : 1, a fraction of
the target alcohol was collected (110 mg, 87%). 1H NMR (CDCl3,
500 MHz): d 8.60 (m, 2H, 2  H-a), 8.46 (m, 2H, 2  H-a0), 7.64–
7.61 (m, 4H, 2  H-b, 2  H-c), 5.68 (s, 2H, 2  CHOH). 13C
NMR (CDCl3, 125 MHz): d 130.86(3C), 128.90(3C) (6  Cquat),
126.88(2C) (2  C-b), 126.70(2C) (2  C-c), 125.81(2C) (2  C-a),
124.39(2C) (2  C-a0), 57.57 (CH2OH). HRMS (MALDI) calcd for
C15H11ClO 242.0498, found 242.0497.
10-Chloro-9-anthracenemethyl chloride (9). 10-Chloro-9-
anthracenemethanol (8, 110 mg, 0.454 mmol, 1 equiv.) was
suspended in dichloromethane (5 mL) with pyridine (55 mL,
0.683 mmol, 1.5 equiv.) and cooled to 0 C. Thionyl chloride (40
mL, 0.551 mmol, 1.2 equiv.) was added, and the mixture was
stirred for 18 h at room temperature. Water was added and the
mixture was extracted with dichloromethane. The collected
organic layers were washed with sodium bicarbonate solution,
then dried with MgSO4 and concentrated. The residue was pure
chloride according to NMRref (103 mg, 88%). 1H NMR (CDCl3,
500 MHz): d 8.61 (d, 2H, 3JHa,Hb ¼ 8.9 Hz, 2  H-a), 8.35 (d, 2H,
3JHa0,Hc ¼ 8.8 Hz, 2  H-a0), 7.69–7.63 (m, 4H, 2  H-b, 2  H-c),
5.61 (s, 2H, 2  CHCl). 13C NMR (CDCl3, 125 MHz):
d 130.52(3C), 128.90(3C) (6  Cquat), 127.34(2C) (2  C-b),
126.83(2C) (2  C-c), 126.00(2C) (2  C-a), 123.93(2C) (2 
C-a0), 38.99 (CH2Cl). HRMS (MALDI) calcd for C15H10Cl2
260.0160, found 260.0159.
N-(10-Chloro-9-anthracenemethyl)-1-deoxynojirimycin (6). 1-
Deoxynojirimycin (1, 50 mg, 0.304 mmol, 1 equiv.) was dis-
solved in dry DMF (2.5 mL) and 10-chloro-9-anthracenemethyl
chloride (9, 103 mg, 0.396 mmol, 1.3 equiv.) and anhydrous
potassium carbonate (124 mg, 0.899 mmol, 2.9 equiv.) were
added. Themixture was heated to 80 C until TLC indicated that
the starting material was consumed (ca. 4 h). The mixture was
ltered, concentrated and subjected to gradient column chro-
matography on silica gel starting with chloroform–methanol
4 : 1, then 7 : 3, then 1 : 4 and nally ethyl acetate–methanol
1 : 4. A fraction of crude target molecule was collected (112 mg,7390 | Chem. Sci., 2017, 8, 7383–739388%). Crystallization from methanol–dichloromethane led to
crystals of pure N-(10-chloro-9-anthracenemethyl)-1-
deoxynojirimycin (6, 61 mg, 48%), [a]25D ¼ 27.6 (c ¼ 0.4,
methanol). HRMS (MALDI) calcd for C21H22ClNO4 [M + Na]
+
410.1130, found 410.1137.
9-Chloro-10-(2-methoxyvinyl)anthracene (10). To a mixture
of Ph3P
+CH2OCH3 Cl
 (440 mg, 1.25 mmol, 1.5 equiv.) in dry
THF (10 mL) under nitrogen at 0 C, n-BuLi (0.78 mL,
1.25 mmol, 1.5 equiv., 1.6 M in hexane) was added dropwise.
The reaction mixture was stirred at 0 C for 20 min, then
a solution of 10-chloro-9-anthracenecarboxaldehyde (7, 200 mg,
0.83 mmol, 1 equiv.) was added. The reaction mixture was
stirred at room temperature overnight. Aer that, the reaction
mixture was ltered to remove triphenylphosphine oxide. Water
and diethyl ether were added, and the aqueous phase was
extracted with diethyl ether. The combined organic layers were
dried over MgSO4, ltered and concentrated under vacuum. The
residue was puried by ash chromatography (PE/DCM: 3/1) to
give a mixture of E and Z isomers of 10 (134 mg, 60%, E/Z ¼
1.4/1) as yellow solids.
2-(10-Chloroanthracen-9-yl)acetaldehyde (11). A solution of
enol ether 10 (134 mg, 0.499 mmol, 1 equiv.) in diethyl ether
(3 mL) was added dropwise to a pre-cooled mixture of 70%
HClO4 (0.246 mL, 1.99 mmol, 4 equiv.), H2O (0.246 mL) and
diethyl ether (3 mL). The reaction mixture was then reuxed at
40 C. Aer being stirred overnight, the reaction mixture was
cooled to room temperature, then sat. NaHCO3 was added to
neutralize the acid. The aqueous phase was extracted with
diethyl ether. The combined organic layers were dried over
MgSO4, ltered and concentrated under vacuum. The crude
yellow solid 13 (110 mg, 89%) was pure enough to be used
directly in the next step. 1H NMR (CDCl3, 500 MHz): d 9.71
(m, 1H, CH2CHO), 8.53 (d, 2H,
3JHa,Hb ¼ 9.1 Hz, 2  H-a), 8.09
(d, 2H, 3JHa0,Hc ¼ 9.2 Hz, 2  H-a0), 7.57–7.49 (m, 4H, 2  H-b, 2
 H-c), 4.59 (m, 2H, 2  CHCHO).
1-(2-(10-Chloroanthracen-9-yl)ethyl)-1-deoxynojirimycin (12).
Amixture of 1-DNJ (1, 25 mg, 0.152 mmol, 1 equiv.) and aldehyde
11 (39 mg, 0.153 mmol, 1 equiv.) in methanol (15 mL) and
chloroform (1 mL) was heated to reux until a homogenous
solution was formed. Then NaBH3CN (19 mg, 0.304 mmol, 2
equiv.) and acetic acid (0.018 mL, 0.304 mmol, 2 equiv.) were
added. The reaction mixture was reuxed for 3 h. Aer that, the
solvent was evaporated and the residue was puried by ash
chromatography (CHCl3, then CHCl3/MeOH 8/1) to give 12
(34 mg, 55%) as a yellow solid. Rf ¼ 0.25 (DCM/MeOH: 8/1). 1H
NMR (DMSO-d6, 500 MHz): d 8.50 (d, 2H,
3JHa,Hb¼ 8.8 Hz, 2 H-
a), 8.47 (d, 2H, 3JHa0,Hc ¼ 8.8 Hz, 2  H-a0), 7.72 (m, 2H, 2 H-b),
7.67 (m, 2H, 2 H-c), 4.82 (d, 1H, 3JH2,OH¼ 4.6 Hz, C2–OH), 4.78
(m, 2H, C3–OH, C4–OH), 4.49 (t, 1H, 3JH6,OH ¼ 5.1 Hz, C6–OH),
3.95–3.84 (m, 2H, H-6, H-20), 3.78–3.73 (m, 1H, H-20), 3.62–3.57
(m, 1H, H-6), 3.33–3.30 (m, 1H, H-2), 3.15–3.11 (m, 1H, H-1),
3.04–2.95 (m, 4H, H-3, H-4, 2  H-10), 2.56–2.54 (m, 1H, H-1),
2.33–2.29 (m, 1H, H-5). 13C NMR (DMSO-d6, 125 MHz):
d 129.92(3C), 127.94(3C) (6  Cquat), 127.23(2C) (2  C-b),
126.19(2C) (2  C-c), 125.12(2C) (2  C-a), 124.67(2C) (2  C-a0),
79.12 (C-4), 70.92 (C-3), 69.49 (C-2), 66.08 (C-5), 60.15 (C-6), 57.36This journal is © The Royal Society of Chemistry 2017
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View Article Online(C-1), 53.41 (C-10), 23.15 (C-20). HRMS (ESP): calcd for
C22H25ClNO4 [M + H]
+: 402.1467; found: 402.1467.
9-Chloro-10-(3-methoxyallyl)anthracene (13). To a mixture of
Ph3P
+CH2OCH3 Cl
 (158 mg, 0.447 mmol, 1.5 equiv.) in dry THF
(10 mL) under nitrogen at 0 C, n-BuLi (0.28 mL, 0.447 mmol,
1.5 equiv., 1.6 M in hexane) was added dropwise. The reaction
mixture was stirred at 0 C for 20 min, then a solution of 2-(10-
chloroanthracen-9-yl)acetaldehyde (11) (76 mg, 0.298 mmol,
1 equiv.) was added. The reaction mixture was stirred at room
temperature overnight. Aer that, the reaction mixture was
ltered to remove triphenylphosphine oxide. Water and diethyl
ether were added and the aqueous phase was extracted with
diethyl ether. The combined organic layers were dried over
MgSO4, ltered and concentrated under vacuum. The residue
was puried by ash chromatography (PE/DCM: 3/1) to give the Z
isomer (15 mg, 18%) and E isomer (30 mg, 35%) as yellow solids.
Z isomer: Rf ¼ 0.67 (PE/DCM: 3/2) 1H NMR (CDCl3, 500 MHz):
d 8.58 (d, 2H, 3JHa,Hb ¼ 8.8 Hz, 2  H-a), 8.40 (d, 2H, 3JHa0,Hc ¼
9.0 Hz, 2H-a0), 7.62–7.55 (m, 4H, 2H-b, 2H-c), 5.98 (d, 1H,
3J ¼ 6.0 Hz, CHOCH3), 4.57 (m, 1H, CHCHOCH3), 4.39 (m, 2H,
2  CHCHCHOCH3), 3.79 (s, 3H, OCH3). 13C NMR (CDCl3, 125
MHz): d 146.09 (CHOCH3), 133.88(2C), 130.29(2C), 128.90(2C)
(6 Cquat), 126.45(2C) (2  C-b), 125.82(2C) (2  C-c), 125.64(2C)
(2  C-a), 125.25(2C) (2  C-a0), 105.25 (CHCHOCH3), 55.99
(CHCHCHOCH3), 23.29 (OCH3). HRMS (ESP): calcd for C18H15-
ClONa [M + Na]+: 305.0709; found: 305.1090.
E isomer: Rf¼ 0.57 (PE/DCM: 3/2). 1H NMR (CDCl3, 500 MHz):
d 8.58 (d, 2H, 3JHa,Hb ¼ 8.9 Hz, 2  H-a), 8.30 (d, 2H, 3JHa0,Hc ¼
8.8 Hz, 2H-a0), 7.62–7.54 (m, 4H, 2H-b, 2H-c), 6.33 (d, 1H,
3J ¼ 13.1 Hz, CHOCH3), 5.07 (m, 1H, CHCHOCH3), 4.25 (m, 2H,
2  CHCHCHOCH3), 3.42 (s, 3H, OCH3). 13C NMR (CDCl3, 125
MHz): d 148.68 (CHOCH3), 139.59(2C), 130.17(2C), 128.77(2C)
(6 Cquat), 126.35(2C) (2  C-b), 125.93(2C) (2  C-c), 125.61(2C)
(2  C-a), 124.85(2C) (2  C-a0), 101.19 (CHCHOCH3),
55.90 (CHCHCHOCH3), 26.35 (OCH3). HRMS (ESP): calcd for
C18H15ClONa [M + Na]
+: 305.0709; found: 305.2644.
3-(10-Chloroanthracen-9-yl)propanal (14). A solution of the E
isomer of the enol ether 13 (30 mg, 0.106 mmol, 1 equiv.) in
diethyl ether (2 mL) was added dropwise to a pre-cooled mixture
of 70% HClO4 (0.053 mL, 0.424 mmol, 4 equiv.), H2O (0.053 mL)
and diethyl ether (1 mL). The reactionmixture was then reuxed
at 40 C. Aer being stirred for 2 h, the reaction mixture was
cooled to room temperature, then sat. NaHCO3 was added to
neutralize the acid. The aqueous phase was extracted with
dichloromethane. The combined organic layers were dried over
MgSO4, ltered and concentrated under vacuum. The residue
was puried by ash chromatography (PE/DCM: 3/1, then 2/1)
to give aldehyde 14 (21 mg, 78%) as a yellow solid. Rf ¼ 0.25
(PE/DCM: 3/2). 1H NMR (CDCl3, 500 MHz): d 9.89 (br, 1H,
CH2CH2CHO), 8.53 (d, 2H,
3JHa,Hb¼ 9.2 Hz, 2H-a), 8.16 (d, 2H,
3JHa0,Hc ¼ 9.2 Hz, 2  H-a0), 7.57–7.50 (m, 4H, 2  H-b, 2  H-c),
3.88 (m, 2H, 2  CHCH2CHO), 2.89 (m, 2H, 2  CH2CHCHO).
1-(3-(10-Chloroanthracen-9-yl)propyl)-1-deoxynojirimycin
(15). A mixture of 1-DNJ (1, 10 mg, 0.060 mmol, 1 equiv.) and
aldehyde 14 (16 mg, 0.060 mmol, 1 equiv.) in methanol (10 mL)
and chloroform (1 mL) was heated to reux until a homogenous
solution was formed. Then NaBH3CN (7.5 mg, 0.120 mmol,This journal is © The Royal Society of Chemistry 20172 equiv.) and acetic acid (0.007 mL, 0.120 mmol, 2 equiv.) were
added. The reaction mixture was reuxed overnight. Aer that,
the solvent was evaporated, and the residue was puried by
ash chromatography (CHCl3, then CHCl3/MeOH 8/1) to give 15
(23 mg, 82%) as a yellow solid.
Rf ¼ 0.50 (DCM/MeOH: 7/1). 1H NMR (DMSO-d6, 500 MHz):
d 8.47 (t, 4H, 3JHa,Hb ¼ 3JHa0,Hc ¼ 8.8 Hz, 2  H-a, 2  H-a0), 7.74
(m, 2H, 2  H-b), 7.65 (m, 2H, 2  H-c), 4.70 (m, 2H, C3–OH,
C4–OH), 4.67 (d, 1H, 3JH2,OH ¼ 4.5 Hz, C2–OH), 4.36 (t, 1H,
3JH6,OH ¼ 5.1 Hz, C6–OH), 3.85 (m, 1H, H-6), 3.67–3.49 (m, 3H,
H-6, 2  H-30), 3.33–3.30 (m, 1H, H-2), 3.14–3.05 (m, 2H, H-10,
H-4), 2.98–2.85 (m, 2H, H-3, H-1), 2.71 (m, 1H, H-10), 2.01–1.72
(m, 4H, H-5, H-1, 2  H-20). 13C NMR (DMSO-d6, 125 MHz):
d 129.51(3C), 127.94(3C) (6  Cquat), 127.20(2C) (2  C-b),
126.14(2C) (2  C-c), 125.17(2C) (2  C-a), 124.66(2C) (2  C-
a0), 79.17 (C-3), 71.02 (C-4), 69.50 (C-2), 66.87 (C-5), 59.58 (C-6),
57.17 (C-1), 52.06 (C-10), 26.90 (C-20), 25.44 (C-30). HRMS (ESP):
calcd for C23H27ClNO4 [M + H]
+: 416.1629; found: 416.1632.
2,3,4,6-Tetra-O-tert-butyldimethylsilyl-D-glucono-d-lactam (17).
Lactam 16 (70 mg, 0.393 mmol, 1 equiv.) and DMAP (9.6 mg,
0.079 mmol, 0.2 equiv.) were dissolved in pyridine (10 mL). The
solution was cooled to 0 C, and tert-butyldimethylsilyl triate
(0.828 mL, 3.54 mmol, 9 equiv.) was added. The reaction mixture
was heated to 60 C and stirred overnight. Then methanol was
added, and the solution was diluted with ethyl acetate. The
organic phase was washed with water (3 20 mL). The combined
organic layers were dried over MgSO4, ltered and concentrated
under vacuum. The residue was puried by ash chromatography
(PE/EtOAc: 30/1, then 20/1) and aﬀorded lactam 17 (150 mg, 60%)
as a white solid. Rf ¼ 0.50 (PE/EtOAc: 10/1). 1H NMR (CDCl3, 500
MHz): d 3.96 (m, 1H, H-3), 3.86 (d, 1H, 3JH2,H3 ¼ 3.3 Hz, H-2), 3.79
(m, 1H, H-6), 3.65 (m, 1H, H-5), 3.56 (m, 1H, H-4), 3.49 (dd, 1H,
3JH5,H6¼ 8.4 Hz, 2JH6,H60 ¼ 10.3 Hz, H-6), 0.88 (s, 9H, C(CH3)3), 0.87
(br, 18H, 2 C(CH3)3), 0.85 (s, 9H, C(CH3)3), 0.13, 0.12, 0.10, 0.08,
0.07, 0.06 (6s, 18H, 6  SiCH3), 0.05 (s, 6H, 2  SiCH3). 13C NMR
(CDCl3, 125 MHz): d 171.28 (NCOCH), 77.92 (C-2), 74.87 (C-3),
73.83 (C-4), 58.32 (C-5), 63.86 (C-6), 25.93(3C), 25.85(6C),
25.80(3C) (12  C(CH3)), 18.32, 18.22, 18.01, 17.96 (4  C(CH3)3),
3.72, 4.12, 4.53, 4.74, 4.86, 5.06, 5.25, 5.29 (8 
SiCH3). HRMS (ESP): calcd for C30H68NO5Si4 [M + H]
+: 635.2160;
found: 635.3584.
N-(10-Chloro-9-anthracenemethyl)-2,3,4,6-tetra-O-tert-butyl-
dimethylsilyl-D-glucono-d-lactam (18). To a solution of 17
(75 mg, 0.118 mmol, 1 equiv.) in THF (5 mL), sodium hydride
(9.5 mg, 0.236 mmol, 2 equiv., 60% in mineral oil) was added
portionwise under nitrogen. The mixture was stirred for 15 min.
Tetrabutylammonium iodide (8.7 mg, 0.024 mmol, 0.2 equiv.)
was added, followed by dropwise addition of 10-chloro-9-
anthracenemethyl chloride (9, 62 mg, 0.236 mmol, 2 equiv.).
The reaction mixture was stirred at room temperature overnight.
Water was added slowly and the mixture was extracted with
diethyl ether (3  30 mL). The combined organic layers were
dried over MgSO4, ltered and concentrated under vacuum. The
residue was puried byash chromatography (PE/DCM: 5/1, then
4/1) and aﬀorded lactam 18 (50 mg, 49%) as a yellow solid. Rf ¼
0.32 (PE/DCM: 2/1). 1H NMR (CDCl3, 500 MHz): d 8.58 (d, 2H,
3JHa,Hb ¼ 8.9 Hz, 2  H-a), 8.47 (d, 2H, 3JHa0,Hc ¼ 8.7 Hz, 2H, 2 Chem. Sci., 2017, 8, 7383–7393 | 7391
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View Article OnlineH-a0), 7.60 (m, 2H, 2  H-b), 7.55 (m, 2H, 2  H-c), 6.01 (d, 1H,
2J ¼ 15.6 Hz, H-10), 5.51 (d, 1H, 2J ¼ 15.0 Hz, H-10), 4.06 (d, 1H,
3JH2,H3¼ 3.5 Hz, H-2), 3.89 (m, 1H, H-4), 3.82 (m, 1H, H-3), 3.53 (t,
1H, H-6), 3.36 (m, 1H, H-5), 2.61 (dd, 1H, H-6), 0.98, 0.82, 0.73,
0.57 (4s, 36H, 4  C(CH3)3), 0.35, 0.25, 0.11, 0.05, 0.09, 0.21,
0.45, 0.72 (8s, 24H, 8  SiCH3). 13C NMR (CDCl3, 125 MHz):
d 170.48 (NCOCH), 132.03(2C), 128.91(2C), 128.25(2C) (6 Cquat),
126.93(2C) (2  C-b), 126.67(2C) (2  C-c), 125.82(2C) (2  C-a),
125.21(2C) (2  C-a0), 81.58 (C-3), 76.25 (C-2), 70.14 (C-4), 64.58
(C-5), 61.86 (C-6), 42.59 (C-10), 26.46(3C), 26.04(3C), 25.77(3C),
25.72(3C) (12 C(CH3)), 18.90, 18.01, 17.96, 17.93 (4 C(CH3)3),
3.17, 3.90, 4.17, 4.49, 4.54, 4.69, 5.55, 6.40 (8 
Si(CH3)). HRMS (ESP): calcd for C45H77ClNO5Si4 [M + H]
+:
858.4561; found: 858.4529.
N-(10-Chloro-9-anthracenemethyl)-D-glucono-d-lactam (19).
To a solution of lactam 18 (100 mg, 0.116 mmol, 1 equiv.) in
THF (10 mL), tetrabutylammonium uoride (1.36 mL,
0.928 mmol, 8 equiv.) was added. The reaction mixture was
stirred at room temperature overnight. Then the solvent was
evaporated and lactam 19 was collected and recrystallized from
methanol. Yield: 7 mg (14%). Rf ¼ 0.30 (DCM/MeOH: 9/1). 1H
NMR (DMSO-d6, 500 MHz): d 8.52 (d, 2H,
3JHa,Hb ¼ 8.9 Hz, 2 
H-a), 8.44 (d, 2H, 3JHa0,Hc ¼ 8.9 Hz, 2H, 2  H-a0), 7.74 (m, 2H, 2
 H-b), 7.66 (m, 2H, 2  H-c), 6.06 (d, 1H, 2J ¼ 15.5 Hz, H-10),
5.32 (d, 1H, 2J¼ 15.5 Hz, H-10), 5.11 (d, 1H, 3JH3,OH¼ 4.5 Hz, C3–
OH), 5.04 (t, 1H, 3JH6,OH¼ 5.3 Hz, C6–OH), 5.02 (d, 1H, 3JH2,OH¼
4.3 Hz, C2–OH), 4.81 (d, 1H, 3JH4,OH¼ 4.3 Hz, C4–OH), 3.81 (dd,
1H, 3JH2,OH ¼ 4.1 Hz, 3JH2,H3 ¼ 9.5 Hz, H-2), 3.55 (m, 1H, H-6),
3.46 (m, 1H, H-4), 3.11 (m, 1H, H-6), 2.99 (m, 1H, H-3), 2.52
(m, 1H, H-5). 13C NMR (DMSO-d6, 125 MHz): d 171.33 (NCOCH),
131.21(2C), 128.62(2C), 127.82(2C) (6  Cquat), 127.34(2C) (2 
C-b), 126.83(2C) (2  C-c), 124.89(2C) (2  C-a), 124.85(2C) (2 
C-a0), 74.12 (C-3), 70.19 (C-2), 70.14 (C-4), 61.79 (C-5), 59.66 (C-6),
39.14 (C-10). HRMS (ESP): calcd for C21H21ClNO5 [M + H]
+:
402.1108; found: 402.1109.Determination of the pKa values of iminosugars 6, 12 and 15
by uorescence titration
Iminosugars 6, 12 and 15 were each dissolved in DMSO to give 8
mmol L1 stock solutions. 0.05 mL was added to 0.45 mL of
phosphate buﬀers with diﬀerent pH values (2.2, 3.0, 4.0, 4.4, 5.0,1
KiðobsÞ ¼
1
Kið1Þ  KAE1  KAE2  KAI
H3
þ KAE1  KAE2
H2
þ KAE1 
H2

þ 1
Kið2Þ  KAE2  KAI
H2
þ KAE2
H
þ KAI
H
þ 1þ KAI
KAE1
þ H
KA

þ 1
Kið4Þ  1þ H
KAI
þ H
KAE2
þ H
2
KAI  KAE2 þ
H2
KAE1  KA

7392 | Chem. Sci., 2017, 8, 7383–73935.2, 5.4, 5.6, 6.0, 6.4, 6.6, 6.8, 7.0, 7.4, 7.8, 8.0). Fluorescence
spectra of each solution were recorded with excitation at 358 nm.
Procedure for uorescence measurements
The inhibitors 6, 12, 15 and 19 were dissolved at 0.012 mg mL1
in DMSO and diluted 4 times with DMSO to create stock solu-
tions of approximately 8.0 mM. Normally the uorescence was
measured for the following types of solution:
(A) Blank (0.45 mL phosphate buﬀer and 0.05 mL DMSO).
(B) Inhibitor (0.45 mL phosphate buﬀer and 0.05 mL inhib-
itor stock solution, [I] ¼ 0.8 mM).
(C) Enzyme (0.1–0.2 mL enzyme stock solution in phosphate
buﬀer, 0.25–0.35 mL phosphate buﬀer and 0.05 mL DMSO.
[E] ¼ 5.8–72 mM).
(D) Enzyme and inhibitor (0.1–0.2 mL enzyme stock solution
in phosphate buﬀer, 0.25–0.35 mL phosphate buﬀer and
0.05 mL inhibitor stock solution. [I] ¼ 0.8 mM, [E] ¼ 5.8–72 mM).
Fluorescence spectra were taken for samples A–D excited at
358 nm on a Perkin Elmer LS50 instrument. The subtracted
spectra (B A), (D C) and (D C B + A) gave the net eﬀect of
the inhibitor uorescence when bound.
Procedure for measuring glycosidase inhibition
These experiments were performed at 37 C in aqueous phos-
phate buﬀer (0.1 M) containing 10% DMSO to make sure the
inhibitor was completely dissolved. The substrate was either 4-
nitrophenyl a- or b-D-glucopyranoside, depending on whether
the enzyme was a- or b-glucosidase. In a platereader, 5–8 reac-
tions with varying substrate concentrations (1–20 mM) were
simultaneously started by the addition of enzyme (0.3 nM), and
the formation of 4-nitrophenol followed. The absorbance was
measured at 400 nm for 10–20 minutes. This procedure was
performed with and without the inhibitor at a concentration
close to the expected Ki. From these data, Km could be deter-
mined with and without inhibition, and from those values Ki
was calculated (using Ki ¼ [I]/(Km0/Km  1)).
Analysis of inhibition–pH data
The previously published method was used.18 1/Ki has the
following dependence on the H concentration:KAI þ KAE1
H
þ KAI
H
þ 1

E1
þ 1
Kið3Þ  KAE2
H
þ KAE2
KAI
þ 1þ H
KAI
þ H
KAE1
þ H
2
KAI  KAE1
 
E2
þ H
3
KAI  KAE1  KAE2

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View Article OnlineThe EHI and EI binding curves shown in Fig. 4 and 5 were
made in a spreadsheet by entering the relevant acid constants
(5: 105.1, b-glucosidase: 104.4 and 106.7) and reasonable
values for the constants Ki(1–4).
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